Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.

ACP-01 is safe, clinically relevant and statistically significant as a treatment for peripheral arterial disease, chronic limb threatening ischemia, non ischemic dilated cardiomyopathy, ischemic ...

Chagas cardiomyopathy is the most important clinical manifestation of Chagas disease, resulting in the majority of Chagas morbidity and mortality. 134 Although generally classified as having a ...